MyHealthChecked (MHC) has welcomed a UK government announcement that COVID-19 testing companies will be removed from the approved list if they advertise misleading prices, emphasising that it provides “clear, transparent and market competitive pricing… also ensures a high standard of service and robust laboratory capacity planning methods to ensure customer needs are met”.
MyHealthChecked (MHC) has made a trading update, emphasising “the first half of 2021 has seen a transformation of our business” and the shares have responded more than 7% higher to 3.8p – so what’s the transformation?
MyHealthChecked (MHC) has announced an acquisition which it emphasises represents expansion which sits well alongside its home-administered postal genomic testing services and currently its COVID-19 sample collection kit and service.
MyHealthChecked (MHC) has announced results for the 2020 calendar year and that “the impact of our COVID testing business is expected to have a material impact on the company's performance in 2021”, whilst also “a strong pipeline outside of COVID-19 building, life after COVID is exciting, and we enter this phase with growing confidence in the road to delivery”. That sounds encouraging.
MyHealthChecked (MHC) has announced it has “signed a manufacturing agreement and placed a further purchase order of £1.425m with EKF Diagnostic Holdings plc (EKF) for PrimeStore® MTM sample collection devices”. This looks a potentially significant indicator.
There are no numbers in a latest RNS from MyHealthChecked (MHC) but those close to the company talk of numbers for this year which are off the wall. As such you would currently be insane to sell – when the market twigs these shares will surge well past 10p...
This is good news for we loyal shareholders but not the great news. That, I now expect, is to be announced early next week.
My suggestion, made to AIM Regulation and HERE, that shares in all covid testing stocks be suspended on Monday seems to have aroused every idiot who has ever bought an AIM listed share into outrage and anger. Brokerman Dan has joined this populist outrage.
Yes, even MyHealthChecked (MHC) where I am a shareholder should have its shares suspended. The reason is a webpage which went live yesterday and which is now being widely discussed on social media which seems to show that the Government is soon to announce contracts worth £8 billion for covid test suppliers. This is going to cause share price mayhem on Monday.
Reader SB asks if there are any forecasts for MyHealthChecked (MHC). There are not. Not even from the UK’s leading healthcare analyst Mr Brokerman Dan Levi. However, the company does give indications of what sort of sales it might achieve in a corporate presentation video below. There is more and I am not sure what this means and think MyHealthChecked should clarify.
Last year, we discovered on Friday that MyHealthChecked (MHC) lost £2.5 million on sales of £50,000. Yes that is dreadful but this company is now about the future of its Covid and other DNA tests and thus it has raised £3.4 million at 1.75p. It was not completely out of cash so, after costs, it probably has c£3.5 million in the bank.
